| Marksans Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524404 |
NSE Symbol : MARKSANS |
P/E(TTM) : 36.46 |
|
ISIN Demat : INE750C01026 |
Div & Yield% : 0.41 |
EPS(TTM) : 5.32 |
|
Book Value(₹) : 32.99 |
Market Cap(₹Cr) : 8,789.11 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 320.44 | 319.73 | 299.36 | 311.87 | 308.63 | 254.53 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 320.44 | 319.73 | 299.36 | 311.87 | 308.63 | 254.53 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 58.19 | 2.01 | 6.64 | 22.51 | 20.23 | 8.15 |
| Total Income | 378.63 | 321.74 | 305.99 | 334.37 | 328.85 | 262.68 |
| Total Expenditure | 248.37 | 249.68 | 247.60 | 251.93 | 245.22 | 213.26 |
| PBIDT | 130.26 | 72.06 | 58.39 | 82.45 | 83.63 | 49.42 |
| Interest | 0.32 | 0.30 | 0.31 | 0.30 | 0.28 | 0.28 |
| PBDT | 129.95 | 71.76 | 58.08 | 82.14 | 83.35 | 49.14 |
| Depreciation | 8.46 | 8.19 | 8.18 | 7.42 | 7.02 | 6.84 |
| Tax | 20.81 | 14.54 | 11.56 | 17.62 | 12.61 | 10.36 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.88 | 0.98 | 0.75 | 1.64 | 0.52 | -0.07 |
| Reported Profit After Tax | 99.81 | 48.06 | 37.59 | 55.46 | 63.20 | 32.02 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 99.81 | 48.06 | 37.59 | 55.46 | 63.20 | 32.02 |
| EPS (Unit Curr.) | 2.20 | 1.06 | 0.83 | 1.22 | 1.39 | 0.71 |
| EPS (Adj) (Unit Curr.) | 2.20 | 1.06 | 0.83 | 1.22 | 1.39 | 0.71 |
| Calculated EPS (Unit Curr.) | 2.20 | 1.06 | 0.83 | 1.22 | 1.39 | 0.71 |
| Calculated EPS (Adj) (Unit Curr.) | 2.20 | 1.06 | 0.83 | 1.22 | 1.39 | 0.71 |
| Calculated EPS (Ann.) (Unit Curr.) | 8.81 | 4.24 | 3.32 | 4.90 | 5.58 | 2.83 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 8.81 | 4.24 | 3.32 | 4.90 | 5.58 | 2.83 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 45.32 | 45.32 | 45.32 | 45.32 | 45.32 | 45.32 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 40.65 | 22.54 | 19.50 | 26.44 | 27.10 | 19.42 |
| PBDTM(%) | 40.55 | 22.44 | 19.40 | 26.34 | 27.01 | 19.31 |
| PATM(%) | 31.15 | 15.03 | 12.56 | 17.78 | 20.48 | 12.58 |